Cargando…

Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study

BACKGROUND: Low-dose aspirin is widely used for the prevention of cardiovascular events. The prevalence of gastroduodenal injuries and the risk factor profile including gastroprotective drug therapy needs to be clarified in Japanese patients taking daily aspirin for cardioprotection. METHODS: This M...

Descripción completa

Detalles Bibliográficos
Autores principales: Uemura, Naomi, Sugano, Kentaro, Hiraishi, Hideyuki, Shimada, Kazuyuki, Goto, Shinya, Uchiyama, Shinichiro, Okada, Yasushi, Origasa, Hideki, Ikeda, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019829/
https://www.ncbi.nlm.nih.gov/pubmed/23754512
http://dx.doi.org/10.1007/s00535-013-0839-5
_version_ 1782480217968738304
author Uemura, Naomi
Sugano, Kentaro
Hiraishi, Hideyuki
Shimada, Kazuyuki
Goto, Shinya
Uchiyama, Shinichiro
Okada, Yasushi
Origasa, Hideki
Ikeda, Yasuo
author_facet Uemura, Naomi
Sugano, Kentaro
Hiraishi, Hideyuki
Shimada, Kazuyuki
Goto, Shinya
Uchiyama, Shinichiro
Okada, Yasushi
Origasa, Hideki
Ikeda, Yasuo
author_sort Uemura, Naomi
collection PubMed
description BACKGROUND: Low-dose aspirin is widely used for the prevention of cardiovascular events. The prevalence of gastroduodenal injuries and the risk factor profile including gastroprotective drug therapy needs to be clarified in Japanese patients taking daily aspirin for cardioprotection. METHODS: This Management of Aspirin-induced Gastro-Intestinal Complications (MAGIC) study was conducted with a prospective nationwide, multicenter, real-world registry of Japanese patients at high-risk of cardiovascular diseases who were taking regular aspirin (75–325 mg) for 1 month or more. All patients underwent endoscopic examination for detection of gastroduodenal ulcer and mucosal erosion. The risk factor profiles including the concurrent drug therapy were compared for those patients with gastroduodenal problems and those without. RESULTS: Gastroduodenal ulcer and erosion were detected in 6.5, and 29.2 % of the 1,454 patients receiving aspirin, respectively. H. pylori infection was associated with an increased risk for ulcer: OR 1.83 (1.18–2.88 p = 0.0082). Risk of erosion was lower with enteric-coated aspirin than with buffered aspirin: odds ratio (OR) 0.47 (0.32–0.70, p = 0.0002). Patients receiving proton pump inhibitors had lower risks for both gastroduodenal ulcer and erosion: OR 0.34 (0.15–0.68, p = 0.0050) and 0.32 (0.22–0.46, p < 0.0001), respectively. However, those receiving histamine 2-receptor antagonists had reduced risks for erosion but not for ulcer: OR 0.49 (0.36–0.68, p < 0.0001). CONCLUSION: Gastroduodenal ulcer and erosion are common in Japanese patients taking low dose aspirin for cardioprotection. Proton pump inhibitors reduce the risk of gastroduodenal mucosal injury. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00535-013-0839-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4019829
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-40198292014-05-14 Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study Uemura, Naomi Sugano, Kentaro Hiraishi, Hideyuki Shimada, Kazuyuki Goto, Shinya Uchiyama, Shinichiro Okada, Yasushi Origasa, Hideki Ikeda, Yasuo J Gastroenterol Original Article—Alimentary Tract BACKGROUND: Low-dose aspirin is widely used for the prevention of cardiovascular events. The prevalence of gastroduodenal injuries and the risk factor profile including gastroprotective drug therapy needs to be clarified in Japanese patients taking daily aspirin for cardioprotection. METHODS: This Management of Aspirin-induced Gastro-Intestinal Complications (MAGIC) study was conducted with a prospective nationwide, multicenter, real-world registry of Japanese patients at high-risk of cardiovascular diseases who were taking regular aspirin (75–325 mg) for 1 month or more. All patients underwent endoscopic examination for detection of gastroduodenal ulcer and mucosal erosion. The risk factor profiles including the concurrent drug therapy were compared for those patients with gastroduodenal problems and those without. RESULTS: Gastroduodenal ulcer and erosion were detected in 6.5, and 29.2 % of the 1,454 patients receiving aspirin, respectively. H. pylori infection was associated with an increased risk for ulcer: OR 1.83 (1.18–2.88 p = 0.0082). Risk of erosion was lower with enteric-coated aspirin than with buffered aspirin: odds ratio (OR) 0.47 (0.32–0.70, p = 0.0002). Patients receiving proton pump inhibitors had lower risks for both gastroduodenal ulcer and erosion: OR 0.34 (0.15–0.68, p = 0.0050) and 0.32 (0.22–0.46, p < 0.0001), respectively. However, those receiving histamine 2-receptor antagonists had reduced risks for erosion but not for ulcer: OR 0.49 (0.36–0.68, p < 0.0001). CONCLUSION: Gastroduodenal ulcer and erosion are common in Japanese patients taking low dose aspirin for cardioprotection. Proton pump inhibitors reduce the risk of gastroduodenal mucosal injury. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00535-013-0839-5) contains supplementary material, which is available to authorized users. Springer Japan 2013-06-12 2014 /pmc/articles/PMC4019829/ /pubmed/23754512 http://dx.doi.org/10.1007/s00535-013-0839-5 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by-nc/2.5/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Article—Alimentary Tract
Uemura, Naomi
Sugano, Kentaro
Hiraishi, Hideyuki
Shimada, Kazuyuki
Goto, Shinya
Uchiyama, Shinichiro
Okada, Yasushi
Origasa, Hideki
Ikeda, Yasuo
Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study
title Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study
title_full Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study
title_fullStr Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study
title_full_unstemmed Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study
title_short Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study
title_sort risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular japanese patients: the results from the magic study
topic Original Article—Alimentary Tract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019829/
https://www.ncbi.nlm.nih.gov/pubmed/23754512
http://dx.doi.org/10.1007/s00535-013-0839-5
work_keys_str_mv AT uemuranaomi riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy
AT suganokentaro riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy
AT hiraishihideyuki riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy
AT shimadakazuyuki riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy
AT gotoshinya riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy
AT uchiyamashinichiro riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy
AT okadayasushi riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy
AT origasahideki riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy
AT ikedayasuo riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy
AT riskfactorprofilesdrugusageandprevalenceofaspirinassociatedgastroduodenalinjuriesamonghighriskcardiovascularjapanesepatientstheresultsfromthemagicstudy